[1] GASTAUT H, POIRIER F, PAYAN H, SALAMON G, TOGA M, VIGOUROUX M. H.H.E. syndrome; hemiconvulsions, hemiplegia, epilepsy. Epilepsia. 1960; 1: 418–447.
[2] Tenney JR, Schapiro MB. Child neurology: hemiconvulsion-hemiplegia-epilepsy syndrome. Neurology. 2012; 79(1): e1-4.
[3] Olsen RW, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009; 56: 141–148.
[4] Kodera H, Ohba C, Kato M, Maeda T, Araki K, Tajima D, et al. De novo GABRA1 mutations in Ohtahara and West syndromes. Epilepsia. 2016; 57(4): 566-573.
[5] Johannesen K, Marini C, Pfeffer S, Møller RS, Dorn T, Niturad CE, et al. Phenotypic spectrum of GABRA1: from generalized epilepsies to severe epileptic encephalopathies. Neurology. 2016; 87(11): 1140-1151.
[6] Yang Y, Zhang YH, Chen JY, Ma JH, Sun D, Yang XL, et al. Clinical phenotypes of epilepsy associated with GABRA1 gene variants. Zhonghua Er Ke Za Zhi. 2020; 58(2): 118–122.
[7] Yang Y, Xiangwei W, Zhang X, Xiao J, Chen J, Yang X, et al. Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy. Dev Med Child Neurol. 2020; Online ahead of print.
[8] S Srivastava S, Cohen J, Pevsner J, Aradhya S, McKnight D, Butler E, et al. A novel variant in GABRB2 associated with intellectual disability and epilepsy. Am J Med Genet A. 2014; 164: 2914–2921.
[9] Zou F, McWalter K, Schmidt L, Decker A, Picker JD, Lincoln S, et al. Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype. J Neurogenet. 2017; 31(1–2): 30–36.
[10] Komulainen-Ebrahim J, Schreiber JM, Kangas SM, Pylkäs K, Suo-Palosaari M, Rahikkala E, et al. Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders. Seizure. 2019; 69: 99–104.
[11] Nakashima M, Kato M, Aoto K, Shiina M, Belal H, Mukaida S, et al. De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy. Ann Neurol. 2018; 83(4): 794–806.
[12] Walker MA, Lerman-Sagie T, Swoboda K, Lev D, Blumkin L. Refining the phenotype of the THG1L (p.Val55Ala mutation)-related mitochondrial autosomal recessive congenital cerebellar ataxia. Am J Med Genet A. 2019; 179(8): 1575–1579.
[13] Gayden T, Sepulveda FE, Khuong-Quang DA, Pratt J, Valera ET, Garrigue A, et al. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet. 2018; 50(12): 1650–1657.
[14] Gupta R, Agarwal M, Boqqula VR, Phadke RV, Phadke SR. Hemiconvulsion-hemiplegia-epilepsy syndrome with 1q44 microdeletion: causal or chance association. Am J Med Genet A. 2014; 164A(1): 186–189.